CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands | Total | Common Stock | Accumulated Deficit |
Balance, beginning of period at Jan. 30, 2021 | $ 94,922 | $ 174,391 | $ (79,469) |
Balance, beginning of period (in shares) at Jan. 30, 2021 | | 14,292,250 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | 52 | $ 52 | |
Exercise of stock options (in shares) | | 10,669 | |
Restricted stock issued | | 30,087 | |
Net share settlement of stock options and restricted stock units | (257) | $ (257) | |
Net share settlement of stock options and restricted stock units (in shares) | | (11,339) | |
Stock-based compensation expense | 232 | $ 232 | |
Repurchase and retirement of common stock | (1,356) | | (1,356) |
Repurchase and retirement of common stock (in shares) | | (47,350) | |
Net Income Loss | 1,719 | | 1,719 |
Balance, end of period at May. 01, 2021 | 95,312 | $ 174,418 | (79,106) |
Balance, end of period (in shares) at May. 01, 2021 | | 14,274,317 | |
Balance, beginning of period at Jan. 30, 2021 | 94,922 | $ 174,391 | (79,469) |
Balance, beginning of period (in shares) at Jan. 30, 2021 | | 14,292,250 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | $ 146 | | |
Repurchase and retirement of common stock (in shares) | (1,414,642) | | |
Net Income Loss | $ 9,574 | | |
Balance, end of period at Oct. 30, 2021 | $ 75,763 | $ 175,479 | (99,716) |
Balance, end of period (in shares) at Oct. 30, 2021 | 13,007,409 | 13,007,409 | |
Balance, beginning of period at May. 01, 2021 | $ 95,312 | $ 174,418 | (79,106) |
Balance, beginning of period (in shares) at May. 01, 2021 | | 14,274,317 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | 94 | $ 94 | |
Exercise of stock options (in shares) | | 20,168 | |
Restricted stock issued | | 79,775 | |
Net share settlement of stock options and restricted stock units | (73) | $ (73) | |
Net share settlement of stock options and restricted stock units (in shares) | | 7,582 | |
Stock-based compensation expense | 651 | $ 651 | |
Repurchase and retirement of common stock | (12,008) | | (12,008) |
Repurchase and retirement of common stock (in shares) | | (561,548) | |
Net Income Loss | 626 | | 626 |
Balance, end of period at Jul. 31, 2021 | 84,602 | $ 175,090 | (90,488) |
Balance, end of period (in shares) at Jul. 31, 2021 | | 13,805,130 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Restricted stock issued | | 10,606 | |
Net share settlement of stock options and restricted stock units | (49) | $ (49) | |
Net share settlement of stock options and restricted stock units (in shares) | | (2,583) | |
Stock-based compensation expense | 438 | $ 438 | |
Repurchase and retirement of common stock | $ (16,457) | | (16,457) |
Repurchase and retirement of common stock (in shares) | (805,744) | (805,744) | |
Net Income Loss | $ 7,229 | | 7,229 |
Balance, end of period at Oct. 30, 2021 | $ 75,763 | $ 175,479 | (99,716) |
Balance, end of period (in shares) at Oct. 30, 2021 | 13,007,409 | 13,007,409 | |
Balance, beginning of period at Jan. 29, 2022 | $ 81,126 | $ 175,856 | (94,730) |
Balance, beginning of period (in shares) at Jan. 29, 2022 | 12,631,347 | 12,631,347 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | $ 16 | $ 16 | |
Exercise of stock options (in shares) | | 2,705 | |
Restricted stock issued | | 797,849 | |
Net share settlement of stock options and restricted stock units | (2,375) | $ (2,375) | |
Net share settlement of stock options and restricted stock units (in shares) | | (224,320) | |
Stock-based compensation expense | 548 | $ 548 | |
Repurchase and retirement of common stock | (6,253) | | (6,253) |
Repurchase and retirement of common stock (in shares) | | (479,966) | |
Net Income Loss | (7,855) | | (7,855) |
Balance, end of period at Apr. 30, 2022 | 65,207 | $ 174,045 | (108,838) |
Balance, end of period (in shares) at Apr. 30, 2022 | | 12,727,615 | |
Balance, beginning of period at Jan. 29, 2022 | $ 81,126 | $ 175,856 | (94,730) |
Balance, beginning of period (in shares) at Jan. 29, 2022 | 12,631,347 | 12,631,347 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | $ 16 | | |
Repurchase and retirement of common stock (in shares) | (479,966) | | |
Net Income Loss | $ (40,901) | | |
Balance, end of period at Oct. 29, 2022 | $ 33,065 | $ 174,949 | (141,884) |
Balance, end of period (in shares) at Oct. 29, 2022 | 12,754,368 | 12,754,368 | |
Balance, beginning of period at Apr. 30, 2022 | $ 65,207 | $ 174,045 | (108,838) |
Balance, beginning of period (in shares) at Apr. 30, 2022 | | 12,727,615 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Restricted stock issued | | 28,574 | |
Net share settlement of stock options and restricted stock units | (8) | $ (8) | |
Net share settlement of stock options and restricted stock units (in shares) | | (1,821) | |
Stock-based compensation expense | 617 | $ 617 | |
Net Income Loss | (25,705) | | (25,705) |
Balance, end of period at Jul. 30, 2022 | 40,111 | $ 174,654 | (134,543) |
Balance, end of period (in shares) at Jul. 30, 2022 | | 12,754,368 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Stock-based compensation expense | $ 295 | $ 295 | |
Repurchase and retirement of common stock (in shares) | 0 | | |
Net Income Loss | $ (7,341) | | (7,341) |
Balance, end of period at Oct. 29, 2022 | $ 33,065 | $ 174,949 | $ (141,884) |
Balance, end of period (in shares) at Oct. 29, 2022 | 12,754,368 | 12,754,368 | |